The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Rituximab maintenance for patients with diffuse large B-cell lymphoma in first complete remission: Results from a randomized HOVON-Nordic Lymphoma Group phase III study.
 
Elly J. Lugtenburg
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Genmab; Roche; Sandoz; SERVIER; Takeda
Research Funding - Roche; SERVIER; Takeda
 
Peter Brown
Consulting or Advisory Role - Celgene
 
Bronno van der Holt
No Relationships to Disclose
 
Francesco D'Amore
Consulting or Advisory Role - Kyowa Hakko Kirin; Nordic Nanovector; SERVIER; Takeda
Speakers' Bureau - CTI; SERVIER; Takeda
Research Funding - Amgen; Roche; Sanofi; Takeda
 
Harry R Koene
No Relationships to Disclose
 
Eva de Jongh
No Relationships to Disclose
 
Rob Fijnheer
No Relationships to Disclose
 
Olaf Loosveld
No Relationships to Disclose
 
Lara H Böhmer
Research Funding - Celgene (Inst)
Travel, Accommodations, Expenses - SERVIER
 
Hans Pruijt
No Relationships to Disclose
 
Gregor Verhoef
No Relationships to Disclose
 
Mels Hoogendoorn
Consulting or Advisory Role - Novartis
 
Yavuz Bilgin
No Relationships to Disclose
 
Marcel Nijland
Travel, Accommodations, Expenses - Abbvie; Roche
 
King H Lam
No Relationships to Disclose
 
Bart de Keizer
No Relationships to Disclose
 
Daphne de Jong
Honoraria - Bristol-Myers Squibb; Celgene; Takeda
Research Funding - Genmab
 
Josee M Zijlstra
No Relationships to Disclose